MedTrace Logo

Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars

NCT01789346 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-02-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and efficacy of the 532nm potassium titanyl phosphate (KTP) laser in comparison with the 595nm pulsed-dye laser (PDL) for the treatment of fresh surgical scars.

Conditions

  • Scar
  • Surgical Scar
  • Cicatrix
  • Cicatrix, Hypertrophic
  • Keloid

Interventions

DEVICE

532nm KTP

up to three treatments of 1/2 of Single scar, or one entire, randomized Bilateral scar.

DEVICE

595nm PDL

up to three treatments of 1/2 of Single scar, or one entire, randomized Bilateral scar.

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Tina Alster, MD · Washington Institute of Dermatologic Laser Surgery

  • Elizabeth Tanzi, MD · Washington Institute of Dermatologic Laser Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-03-26
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01789346 on ClinicalTrials.gov